These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1420679)

  • 1. Concepts on the use of liposomal antimicrobial agents: applications for aminoglycosides.
    Karlowsky JA; Zhanel GG
    Clin Infect Dis; 1992 Oct; 15(4):654-67. PubMed ID: 1420679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposome-encapsulated aminoglycosides in pre-clinical and clinical studies.
    Schiffelers R; Storm G; Bakker-Woudenberg I
    J Antimicrob Chemother; 2001 Sep; 48(3):333-44. PubMed ID: 11532996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of liposomes as injectable-drug delivery systems.
    Ostro MJ; Cullis PR
    Am J Hosp Pharm; 1989 Aug; 46(8):1576-87. PubMed ID: 2672806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomes as delivery systems in the prevention and treatment of infectious diseases.
    Bergers JJ; ten Hagen TL; van Etten EW; Bakker-Woudenberg IA
    Pharm World Sci; 1995 Jan; 17(1):1-11. PubMed ID: 7719272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposomal antibiotic formulations for targeting the lungs in the treatment of Pseudomonas aeruginosa.
    Alipour M; Suntres ZE
    Ther Deliv; 2014 Apr; 5(4):409-27. PubMed ID: 24856168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomes for scintigraphic imaging: optimization of in vivo behavior.
    Boerman OC; Oyen WJ; Corstens FH; Storm G
    Q J Nucl Med; 1998 Dec; 42(4):271-9. PubMed ID: 9973842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between aminoglycosides and phospholipids using liposomes: a possible mechanism of nephrotoxicity.
    Aramaki Y; Tsuchiya S
    Pharm Res; 1989 May; 6(5):362-6. PubMed ID: 2748525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The liposomal formulation of doxorubicin.
    Abraham SA; Waterhouse DN; Mayer LD; Cullis PR; Madden TD; Bally MB
    Methods Enzymol; 2005; 391():71-97. PubMed ID: 15721375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications.
    Pinto-Alphandary H; Andremont A; Couvreur P
    Int J Antimicrob Agents; 2000 Jan; 13(3):155-68. PubMed ID: 10724019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-circulating sterically stabilized liposomes in the treatment of infections.
    Bakker-Woudenberg IA; Schiffelers RM; Storm G; Becker MJ; Guo L
    Methods Enzymol; 2005; 391():228-60. PubMed ID: 15721385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug delivery systems. 1. site-specific drug delivery using liposomes as carriers.
    Ranade VV
    J Clin Pharmacol; 1989 Aug; 29(8):685-94. PubMed ID: 2674208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular and serum stability of liposomal 2',3'-dideoxycytidine. Effect of lipid composition.
    Makabi-Panzu B; Gourde P; Désormeaux A; Bergeron MG
    Cell Mol Biol (Noisy-le-grand); 1998 Mar; 44(2):277-84. PubMed ID: 9593578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposomes in the treatment of infections.
    Bakker-Woudenberg IA; Storm G; Woodle MC
    J Drug Target; 1994; 2(5):363-71. PubMed ID: 7704480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bactericidal efficacy of liposomal aminoglycosides against Burkholderia cenocepacia.
    Halwani M; Mugabe C; Azghani AO; Lafrenie RM; Kumar A; Omri A
    J Antimicrob Chemother; 2007 Oct; 60(4):760-9. PubMed ID: 17673475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting microencapsulation of drugs in liposomes.
    Kulkarni SB; Betageri GV; Singh M
    J Microencapsul; 1995; 12(3):229-46. PubMed ID: 7650588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and in vivo drug release rates in liposomal nanocarrier development.
    Drummond DC; Noble CO; Hayes ME; Park JW; Kirpotin DB
    J Pharm Sci; 2008 Nov; 97(11):4696-740. PubMed ID: 18351638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The future of liposomal drug delivery.
    Szoka FC
    Biotechnol Appl Biochem; 1990 Oct; 12(5):496-500. PubMed ID: 2288703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-CD19-targeted liposomal doxorubicin improves the therapeutic efficacy in murine B-cell lymphoma and ameliorates the toxicity of liposomes with varying drug release rates.
    Allen TM; Mumbengegwi DR; Charrois GJ
    Clin Cancer Res; 2005 May; 11(9):3567-73. PubMed ID: 15867261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomes as carriers of antimicrobial agents or immunomodulatory agents in the treatment of infections.
    Bakker-Woudenberg IA; Lokerse AF; ten Kate MT; Melissen PM; van Vianen W; van Etten EW
    Eur J Clin Microbiol Infect Dis; 1993; 12 Suppl 1():S61-7. PubMed ID: 8477767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parenteral aminoglycoside therapy. Selection, administration and monitoring.
    Kumana CR; Yuen KY
    Drugs; 1994 Jun; 47(6):902-13. PubMed ID: 7521830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.